DNMT3A and IDH Mutations in Acute Myeloid Leukemia and Other Myeloid Malignancies: Associations With Prognosis and Potential Treatment Strategies

Leukemia - United Kingdom
doi 10.1038/leu.2014.124
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DNMT3A Mutations and Clinical Features in Chinese Patients With Acute Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2013English

High BCAT1 Expression Mimics IDH Mutations in Acute Myeloid Leukemia

Cancer Discovery
Oncology
2017English

Biological and Clinical Influences of NPM1 in Acute Myeloid Leukemia Patients With DNMT3A Mutations

Cancer Management and Research
Oncology
2018English

Simpson's Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Acute Myeloid Leukemia With NPM1 Somatic Mutations

2020English

New Treatments and Strategies in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Splicing Factor Mutations Predict Poor Prognosis in Patients With De Novo Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

Upregulation of Mir-99a Is Associated With Poor Prognosis of Acute Myeloid Leukemia and Promotes Myeloid Leukemia Cell Expansion

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy